लेवोथायरोक्सिन और लियोथायरोनिन और पियोग्लिटाज़ोन और मेटफॉर्मिन का इंटरैक्शन

Insulin or Oral Hypoglycemics — Initiating thyroid replacement therapy may cause increases in insulin or oral hypoglycemic requirements.

Patients receiving insulin or oral hypoglycemics should be closely watched during initiation of thyroid replacement therapy.

These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers, and isoniazid.